stella
beta
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ — Stella
Home
/
B Lymphocytic Leukemia
/
View on ClinicalTrials.gov
Recruiting
Back to B Lymphocytic Leukemia trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(2 sites)
China
Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality
InstituteHBDH, Tianjin, Tianjin Municipality